Croma announces rebrand for PhilArt
Pharmaceutical company Croma Pharma has unveiled the rebranding of its injectable polynucleotide range, PhilArt, to PolyPhil. The company shares the new name is designed to better reflect the products’ advanced
Pharmaceutical company Croma Pharma has unveiled the rebranding of its injectable polynucleotide range, PhilArt, to PolyPhil. The company shares the new name is designed to better reflect the products’ advanced
On January 20, San Diego plastic surgery practice FACES+ hosted a sold out ‘Faces of the Future: An Exploration of Healthy Aging, Longevity and Aesthetics’ event in partnership with the
Training academy Interface Aesthetics has launched a new polynucleotide training course across its sites in London and Manchester in partnership with aesthetic pharmaceutical company Croma Pharma. Using the PhilArt polynucleotide